Merck CDR (CAD Hedged) (MRK : TSX)
Common Stock
$27.02
CAD
+0.52 (1.96%)
Last updated: 2026-06-24
MRK
Merck CDR (CAD Hedged)
Performance
1 Day
+1.96%
1 Week
+4.81%
1 Month
-1.10%
YTD
+12.49%
Key Statistics
Market Cap
$296.29B
52W High
$27.91
52W Low
$17.11
P/E Ratio
33.40
50 Day MA
$25.90
200 Day MA
$26.10
Beta
-
Dividend Yield
12.27%
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 6/24/2026 | $27.05 | $27.05 | $26.87 | $27.02 | $27.02 | 2,814 |
| 6/23/2026 | $26.45 | $26.50 | $26.45 | $26.50 | $26.50 | 5,272 |
| 6/22/2026 | $25.73 | $25.84 | $25.73 | $25.84 | $25.84 | 454 |
| 6/19/2026 | $25.55 | $25.68 | $25.55 | $25.68 | $25.68 | 473 |
| 6/18/2026 | $25.81 | $25.81 | $25.00 | $25.49 | $25.49 | 4,620 |
| 6/17/2026 | $25.78 | $25.78 | $25.78 | $25.78 | $25.78 | 208 |
| 6/16/2026 | $25.73 | $25.73 | $25.73 | $25.73 | $25.73 | 0 |
| 6/15/2026 | $25.81 | $26.00 | $25.80 | $25.80 | $25.80 | 3,029 |
| 6/12/2026 | $27.15 | $27.15 | $26.63 | $26.63 | $26.63 | 4,427 |
| 6/11/2026 | $27.13 | $27.44 | $27.07 | $27.07 | $27.07 | 2,994 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MRK's historical volatility
30-Day Vol
32.7%
Annualized
90-Day Vol
27.7%
Annualized
Trend (90d)
+8.2%
Annualized drift
90d Mean
C$27.82
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$27.28 | C$24.37 – C$30.54 |
| 60 trading days | C$27.55 | C$23.49 – C$32.31 |
| 90 trading days | C$27.82 | C$22.88 – C$33.82 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Merck CDR (CAD Hedged)
Merck & Co., Inc. operates as a healthcare company worldwide. The company offers human health pharmaceutical for various areas under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. The company has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. It has a collaboration agreement with Antengene Corporation Limited to evaluate the combination of ATG-022, a CLDN18.2-targeting antibody-drug conjugate, and anti-PD-1 therapy, as well as KEYTRUDA (pembrolizumab) in patients with advanced solid tumors. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.
Financials
- Revenue (TTM)
- $0
- EBITDA
- -
- Profit Margin
- 0.00%
- ROE (TTM)
- 3690.70%
- EPS (Diluted)
- 0.00
- Book Value
- -
💰 Recent Dividends
$0.1915
Ex: Dec 15, 2025
$0.1848
Ex: Sep 15, 2025
$0.1851
Ex: Jun 16, 2025
$0.1837
Ex: Mar 17, 2025
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE Report